Smaller Pot Stocks You Should Know

HENDERSON, NV / ACCESSWIRE / March 15, 2019 / The biggest marijuana stocks get the most attention. But the global marijuana market is worth $150 billion annually and that suggests there's plenty of room for smaller pot stocks. Below are a few 'up and coming' cannabis stocks you should know.

One company worth researching now, THC Therapeutics, Inc. (THCT), said the US patent office has accepted ALL 20 claims for their herb dryer The dHydronator, which can reduce moisture content of Cannabis to 10% in only 10-14 hours. The dHydronator® also destroys harmful surface contaminants & pathogens. Start your research today.

Today we are highlighting: THC Therapeutics, Inc. (THCT), Origin House (ORHOF), Curaleaf Holdings, Inc. (CURLF), Acreage Holdings, Inc. (ACRGF), and CV Sciences, Inc. (OTCQB:CVSI).

THC Therapeutics, Inc. (THCT) (Market Cap: $89.206M; Share Price: $6.78) has developed a sanitizing herb dryer, The dHydronator®. Their laboratory-proven product is specifically designed for drying and sanitizing freshly harvested Cannabis and herbs. THCT's product has been tested by two independent laboratories. The testing covered over 6 strains and 9 independent tests to confirm the findings.

As we mentioned earlier, the US patent office has accepted ALL 20 claims for The dHydronator®. This is big. Start your research today.

_______

Origin House (ORHOF) (Market Cap: $495.114M; Share Price: $7.58) announced the launch of Continuum, its wholly-owned California -based distribution platform, formed through the operational integration of RVR Distribution and Alta Supply. ORHOF President, Afzal Hasan , stated, "Our California brand focused business model is powered by statewide distribution. We made strategic acquisitions of companies which had established market know-how and local relationships - RVR Distribution and Alta Supply – and consolidated these companies' operations, into Continuum. Origin House has continued to develop its brand support services, to include contract cultivation, manufacturing and sales, to establish itself as a premier cannabis brand development platform in California focused on accelerating the growth of its partner brands."

_______

Curaleaf Holdings, Inc. (CURLF) (Market Cap: $2.292B; Share Price: $6.8343), a leading vertically integrated cannabis operator in the United States, announced that it will report its financial and operating results for the fourth quarter and full year ended December 31, 2018 after the market close on March 20, 2019. Management will host a conference call and audio webcast that evening at 4:30 p.m. EST to answer questions about the company's operational and financial highlights.

_______

Acreage Holdings, Inc. (ACRGF) (Market Cap: $703.636M; Share Price: $17.0585), the largest vertically integrated, multistate owner of cannabis licenses and assets in the U.S., said Wednesday it would enter the California dispensary market through the acquisition of Kanna. The announcement follows the company reporting its fiscal fourth-quarter financial results Tuesday after the closing bell. For the quarter ended Dec. 31, Acreage Holdings posted revenue of $10.5 million, up by 380 % on the year. The net loss amounted to $217.6 million, driven by non-cash charges and non-recurring items.

_______

CV Sciences, Inc. (CVSI) (Market Cap: $440.813M; Share Price: $4.56) announced their financial results for the year ended December 31, 2018. There was record revenue of $48.2 million for 2018, which represents 133% increase over 2017. The Q4 sales stood at $14.2 million, an increase of 96.4% compared to the prior year period. The company's adjusted EBITDA for 2018 of $14 million was a large improvement over last year's $1.6 million.

Signed by –

Priyanka Goel, CFA.

Legal Disclaimer:

This article was written by Regal Consulting, LLC ("Regal Consulting"). Regal Consulting has agreed to a three-month term consulting agreement with THCT dated 2/14/18. The agreement calls for 50,000 restricted shares of THCT per month. All payments were made directly by THC Therapeutics, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. THCT was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.